Cancer Biopharmaceuticals

Biomedical
Biotech
Biotechnology
Cancer Biopharmaceuticals
Trade Of The Day

$2 Biotech Stock To Buy Now

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. ONCY $1.7400 0.1300 % 8.0700 Oncolytics Biotech Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 8.07% Wk: 7.41% Mo: 48.72% Yrly: 55.36% […]

Read More
Biopharmaceuticals
Biotechnology
Cancer Biopharmaceuticals
Value Investing
Value Stocks

GILD is up 8% from its 52-week low. Where is its bargain price?

No matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores more than two years ago, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names […]

Read More
Biopharmaceuticals
Cancer Biopharmaceuticals
Trade Of The Day

Everything You Need To Know Now About CTI BioPharma Corp. (CTIC)

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $4.9300 0.1200 % 2.4900 Cti Biopharm Corp […]

Read More
Biological Drug Manufacturing
Biopharmaceuticals
Biotechnology
Cancer
Cancer Biopharmaceuticals
Cash
Coronavirus
COVID-19
COVID-19 Pill
Defensive Stocks
Dividend Stocks
Dividend Yields
Dividends
Drug Development
Fibonacci Retracement
Free Cash Flow
Fundamental Analysis
Fundamentals
Oncology
Pharmaceuticals
Technical Analysis
Valuations
Value Investing
Value Stocks

MRK is up about 14% from its December low. Is it a good time to buy?

As I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]

Read More
Cancer
Cancer Biopharmaceuticals
Daily Rundown
Home Furnishings
Oil Royalty Trust
Plush Animal Retailer
Semiconductor

Semiconductors, Plush Animals, Oil Royalty Trust, Furniture, Cancer Medication

Aehr Test Systems (AEHR) Aehr Test Systems primarily designs, engineers, manufactures, and sells test and burn-in equipment for use in the semiconductor industry in North America, Asia, and Europe. It provides full wafer contact test systems, test during burn-in systems, test fixtures, and related accessories. The company offers Advanced Burn-in and Test System family of […]

Read More
Biotech
Cancer
Cancer Biopharmaceuticals
Coronavirus
COVID-19
Dividends
Economy
Fibonacci Retracement
Fundamental Analysis
HeathCare
Immunology Biopharmaceutical
Immunotherapies
Pharmaceuticals
RNA Biotechnology
Technical Analysis
Tumor-Specific Cancer Immunotherapies
Vaccines
Value Investing
Value Stocks

PFE is down about 20% in the last three months, and that’s a good thing for value-focused investors

As recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]

Read More
Autoimmune Diseases
Cancer
Cancer Biopharmaceuticals
One Hot Stock

Immutep Limited (IMMP) – Buy Price: $4.40 or better

Buy Price: $4.40 or better Sell Price: TradersPro Sell Signal Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ‘eftilagimod alpha’ or ‘efti’, which is a recombinant […]

Read More
Cancer Biopharmaceuticals
Daily Rundown
Minimally-Invasive Medical devices
Online Talent Marketplace
Specialty Food
Tumor-Specific Cancer Immunotherapies

Cancer Biopharma, Specialty Food, Minimally-Invasive Medical devices, Tumor-Specific Cancer Immunotherapies, Online Talent Marketplace

Verastem, Inc. (VSTM) Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The Chefs’ Warehouse, Inc. […]

Read More